Drug
Rfviiifc
Rfviiifc: highest development phase Phase 3, developed by Sanofi, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| rFVIIIFc NCT02234323 | Phase 3 | Hemophilia A |
| rFVIIIFc NCT02502149 | Phase 3 | Severe Hemophilia A |
Latest
No recent events.
Follow Rfviiifc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.